Skip to content
ppharmaranks
Menu

Best treatments for female infertility

4 products may treat female infertility, spanning FDA drug classes such as progesterone, gonadotropin. The current highest-rated option is bravelle. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 4 drugs we list for female infertility, 2 are available as lower-cost generics, spanning classes such as progesterone, gonadotropin. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for female infertility — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate

Top-rated picks for female infertility: 1. Bravelle · 2. Crinone · 3. Ovidrel

Top-rated treatments for female infertility, ranked by pharmaranks score
#DrugRatingPharmacy pays
172/100View →
270/100$12View →
370/100View →
4Not yet rated$12View →

Narrow by drug class

Explore the class hubs: progesterone

Full ranking · 4 treatments

Frequently asked

What treats female infertility?
Our catalog lists 4 products that may treat female infertility, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is bravelle.
What is the best-rated treatment for female infertility?
By our independent recall-safety rating — not an efficacy measure — bravelle ranks highest among the products we list for female infertility. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat female infertility?
Treatments for female infertility span FDA drug classes including progesterone, gonadotropin. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.